Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Lack of interferon response in animals to naked siRNAs


RNA interference (RNAi) is rapidly becoming the method of choice for the elucidation of gene function and the identification of drug targets. As with other oligonucleotide-based strategies, RNAi is envisioned to ultimately be useful as a human therapeutic. Unlike previous nucleic acid therapeutics, small interfering RNAs have the potential to elicit immune responses via interactions with Toll-like receptor 3 and trigger interferon responses like long, double-stranded RNA and its analogs, such as poly(I:C)1. Recently, the safety of siRNAs has been questioned because they have been shown to trigger an interferon response in cultured cells2,3,4,5. We show here that it is possible to administer naked, synthetic siRNAs to mice and downregulate an endogenous or exogenous target without inducing an interferon response.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: IL-12 induction in RAW-264.7 cells and in mice.
Figure 2: Efficacy of synthetic siRNA in mice.
Figure 3: IFN-α induction in mice.


  1. Alexopoulou, L., Holt, A.C., Medzhitov, R. & Flavell, R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732–738 (2001).

    CAS  Article  Google Scholar 

  2. Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. & Williams, B.R.G. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 771–772 (2003).

    Article  Google Scholar 

  3. Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.L. & Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263–264 (2003).

    CAS  Article  Google Scholar 

  4. Moss, E.G. & Taylor, J.M. Small-interfering RNAs in the radar of the interferon system. Nat. Cell Biol. 5, 834–839 (2003).

    Article  Google Scholar 

  5. Kim, D.-H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22, 321–325 (2004).

    CAS  Article  Google Scholar 

  6. Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).

    CAS  Article  Google Scholar 

  7. Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347–351 (2003).

    CAS  Article  Google Scholar 

  8. Jackson, A.L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635–637 (2003).

    CAS  Article  Google Scholar 

  9. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135–145 (2001).

    CAS  Article  Google Scholar 

  10. Zuany-Amorim, C., Hastewell, J. & Walker, C. Toll-like receptors as potential therapeutic targets for multiple diseases. Nat. Rev. Drug Discov. 1, 797–807 (2002).

    CAS  Article  Google Scholar 

  11. Lund, J.M. et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101, 5598–5603 (2004).

    CAS  Article  Google Scholar 

  12. Diebold, S.S. et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529–1531 (2004).

    CAS  Article  Google Scholar 

  13. Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526–1529 (2004).

    CAS  Article  Google Scholar 

  14. Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K. & Seya, T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293, 1364–1369 (2002).

    CAS  Article  Google Scholar 

  15. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).

    CAS  Article  Google Scholar 

  16. Zhao, Q., Temsamani, J., Iadarola, P.L., Jiang, Z. & Agrawal, S. Effect of different chemically modified oligodeoxynucleotides on immune stimuation. Biochem. Pharmacol. 51, 173–182 (1996).

    CAS  Article  Google Scholar 

  17. Liu, L., Zhou, X., Shi, J., Xie, X. & Yuan, Z. Toll-like receptor-9 induced by physical trauma mediates release of cytokines following exposure to CpG motif in mouse skin. Immunology 110, 341–347 (2003).

    CAS  Article  Google Scholar 

  18. Chow, J.C., Young, D.W., Golenbock, D.T., Christ, W.J. & Gusovsky, F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689–10692 (1999).

    CAS  Article  Google Scholar 

  19. Lecocq, M. et al. Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volume. J. Gene Med. 5, 142–156 (2003).

    CAS  Article  Google Scholar 

  20. Andrianaivo, F. et al. Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection. J. Gene Med. 6, 877–883 (2004).

    CAS  Article  Google Scholar 

  21. Matsumoto, M. et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171, 3154–3162 (2003).

    CAS  Article  Google Scholar 

  22. Ahmed-Nejad, P. et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958–1968 (2002).

    Article  Google Scholar 

  23. Layzer, J.M. et al. In vivo activity of nuclease-resistant siRNAs. RNA 10, 766–771 (2004).

    CAS  Article  Google Scholar 

  24. Wu, J.C., Sundaresan, G., Iyer, M. & Gambhir, S.S. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 4, 297–306 (2001).

    CAS  Article  Google Scholar 

  25. Zender, L. et al. Caspase 8 small interfering RNA prevent acute liver failure in mice. Proc. Natl. Acad. Sci. USA 100, 7797–7802 (2003).

    CAS  Article  Google Scholar 

  26. Durbin, R.K., Mertz, S.E., Koromilas, A.E. & Durbin, J.E. PKR protection against intranasal vesicular stomatitis virus infection is mouse strain dependent. Viral Immunol. 15, 41–51 (2002).

    CAS  Article  Google Scholar 

  27. Whitmore, M.M. et al. Syntergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res. 64, 5850–5859 (2004).

    CAS  Article  Google Scholar 

  28. Kariko, K., Bhuyan, P., Capodici, J. & Weissman, D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-Like Receptor 3. J. Immunol. 172, 6545–6549 (2004).

    CAS  Article  Google Scholar 

  29. Sioud, M. & Sorensen, D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 312, 1220–1225 (2003).

    CAS  Article  Google Scholar 

  30. Hodges, B.L. et al. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. Mol. Ther. 10, 269–278 (2004).

    CAS  Article  Google Scholar 

Download references


The authors would like to thank Jean Lee and Hu Wong for critical blood chemistry and liver panel analyses. We thank Anton McCaffrey and Mark Kay for a donation of the plasmid used in our studies. J.D.H. acknowledges the Whitaker Foundation for a doctoral fellowship. S.H. is supported by an endowment in Molecular Pathology from the Las Madrinas Foundation at CHLA.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Mark E Davis.

Ethics declarations

Competing interests

M.E.D. is a consultant to and has a financial interest in Insert Therapeutics, Inc.

Supplementary information

Supplementary Fig. 1

RNase digestion of poly(I:C) and siRNA. (PDF 151 kb)

Supplementary Fig. 2

Synthetic siRNA does not alter mouse CBC or liver enzyme levels. (PDF 85 kb)

Supplementary Fig. 3

Degradation kinetics of synthetic siRNA in mouse serum. (PDF 193 kb)

Supplementary Fig. 4

Sequence-specific target down-regulation by siRNA in RAW-264.7 cells. (PDF 97 kb)

Supplementary Fig. 5

Synthetic siRNA accomplishes sequence-specific RNAi of an exogenous target in mice. (PDF 74 kb)

Supplementary Fig. 6

Lack of IL-12 and IFN-a induction by siRNA in C57BL/6 mice. (PDF 94 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Heidel, J., Hu, S., Liu, X. et al. Lack of interferon response in animals to naked siRNAs. Nat Biotechnol 22, 1579–1582 (2004).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing